ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

31
Analysis
Health CareAustralia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
Refresh
05 Jul 2021 12:51

ASX200 Sep21 Index Rebalance Preview: Large Impact Names

We see 3 potential changes to the ASX200 at the Sep rebalance with CNI, PNI and SLK being included and NXL, NRW and GEM being deleted. Passive...

Logo
402 Views
Share
bullishAllkem Ltd
28 May 2021 05:50

ASX200 Index Rebalance Preview: Gold Miners Shining

We see 3 potential changes to the ASX200 in the June review. All inclusions/exclusions have over 3 days of ADV to trade from passive funds. Short...

Logo
306 Views
Share
bullishCodan
01 Mar 2021 06:18

ASX200 Index Rebalance Preview: Three Potential Changes & Some Close Names

We see three potential changes to the ASX200 in the March review while there are another two close adds/deletes. High short interest on the...

Logo
407 Views
Share
12 Jun 2020 11:25

ASX200 Index Review - A Handful of Changes

S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...

Logo
447 Views
Share
bullishMayne Pharma
02 Jan 2018 11:51

Mayne Well Positioned to Weather the Storm; Maintaining FVE and Very High Uncertainty

We maintain our AUD 1.25 fair value estimate for no-moat Mayne Pharma given the recent update by management on the US generic industry trading...

Logo
105 Views
Share
x